You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

Article info

Article menu

Download PDFPDF

XML
Imaging
Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)

Authors

  • Igor V Maev Department of Propedeutics of Internal Diseases and Gastroenterology, A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  • Aleksey A Samsonov Department of Propedeutics of Internal Diseases and Gastroenterology, A. I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  • Liudmila K Palgova Clinical Research and Educational Center in Gastroenterology and Hepatology, Institute of High Medical Technologies of St Petersburg University, Saint Petersburg, Russian Federation PubMed articlesGoogle scholar articles
  • Chavdar S Pavlov Scientific Research Department of Innovation therapy, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  • Elena I Vovk Internal Medicine, Clinical pharmacology and Emergency care department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  • Elena N Shirokova Propedeutics of Internal Medicine Department, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  • Kirill M Starostin Medical Affairs, Sanofi-Aventis SA, Moscow, Russian Federation PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kirill M Starostin; Kirill.Starostin{at}sanofi.com
View Full Text

Citation

Maev IV, Samsonov AA, Palgova LK, et al
Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
BMJ Open Gastroenterology 2020;7:e000341. doi: 10.1136/bmjgast-2019-000341

Publication history

  • Received August 24, 2019
  • Revised December 6, 2019
  • Accepted December 8, 2019
  • First published January 13, 2020.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.